Anna Villa

Anna Villa is Group Leader of the “Pathogenesis and Treatment of Immune and Bone Diseases” Unit at SR-Tiget, San Raffaele Hospital in Milano and Head of Unit at National Research Council. Her team is involved in the study of pathophysiology of autoimmunity of hypomorphic RAG defects and in the development of novel therapeutic approaches (gene therapy and gene editing) of RAG defects and Osteopetrosis. Novel conditioning regimens based on biological compounds are also topics of interest